This secondary analysis of the Comparison of Age-Related Macular Degeneration Treatment Trial randomized clinical trial assesses the association of patient adherence and visual acuity in individuals with neovascular age-related macular degeneration.
This noninferiority randomized clinical trial evaluates once-monthly vs a treat-and-extend regimen of ranibizumab injections in patients with age-related neovascular macular degeneration.
This economic evaluation assesses the incremental cost-effectiveness of combination intravitreal ranibizumab and verteporfin photodynamic therapy compared with ranibizumab monotherapy in patients with polypoidal choroidal vasculopathy.
This cohort study compares the accuracy of The Cancer Genome Atlas classification with the American Joint Committee on Cancer classification for predicting uveal melanoma–related metastasis.
This cross-sectional study of US nationwide emergency department data examines the incidence, common injury mechanisms, and economic burden of ocular trauma open globe injuries in the United States.
This case-control study examines the baseline data and 5-year outcomes of participants in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) who retained good vision despite receiving no therapy for 3 years after release from the 2-year CATT treatment protocol.
This post hoc analysis of a randomized clinical trial evaluates change in visual field throughout 5 years among eyes treated with panretinal photocoagulation injectable ranibizumab for proliferative diabetic retinopathy.
This genome-wide association study calculates the single-nucleotide polymorphism heritability of pigmentary glaucoma and identifies genetic associations with the disease.
This case series describes diffuse or segmental ciliary body mass in 3 individuals, in whom it was a clinical sign and tissue source for biopsy in the diagnosis of ocular sarcoidosis.
This case series examines vascularization and reperfusion of autologous retinal graft after transplant for giant macular holes demonstrated by multimodal imaging.
A woman in her 30s was referred for corneal opacities. Her medical history was notable for keratoconjunctivitis sicca, Hashimoto thyroiditis, and anti–interferon-γ autoantibody syndrome. She had previously been diagnosed with Mycobacterium avium complex infection. On examination, she had no visual concerns. Her visual acuity was 20/20 OU. What is your diagnosis?
A 19-year-old man presented with redness and photophobia that had recurred in the left eye for the past year. The patient had been treated previously with topical corticosteroid therapy and reported temporary relief. A full review of systems was negative for other abnormalities. What would you do next?
A 41-year-old man presented for evaluation of 2 weeks of blurred vision and pain in the left eye. What would you do next?
A 49-year-old woman presented with abnormal retinal pigmentation. The patient’s medical history was significant for type 2 diabetes and thyroid cancer that was in remission. The patient’s brother had been previously diagnosed with pattern dystrophy and hearing loss. What would you do next?
This case report describes a central serous chorioretinopathy–related pigment epithelial defect associated with application of phenylephrine, 2.5%.
A 79-year-old man with a history of blunt trauma noted a new, colored lesion with notable features in his eye.
A 15-year-old boy presents with asymmetric perivenous bone spicule pigment consistent with pigmented paravenous retinochoroidal atrophy.
An elderly patient presented with white corneal deposits on an eye that had been treated with ciprofloxacin, 0.3%, for Pseudomonas aeruginosa; these were associated with changes in pH level pursuant to the infection.
A 13-year-old with a medullar and meningeal relapse of T-cell acute lymphocytic leukemia presents with decreased visual acuity in both eyes from a rare, leukemia-associated cause.
Create a personal account or sign in to: